Earnings Feed
Start Free
Sage Therapeutics, Inc.·4

Feb 23, 6:03 PM ET

IGUCHI KIMI 4

4 · Sage Therapeutics, Inc. · Filed Feb 23, 2023

Insider Transaction Report

Form 4
Period: 2023-02-21
Sage Therapeutics, Inc.SAGE
IGUCHI KIMI
See Remarks
Transactions
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2023-02-23−250→ 4,642 total
    Exercise: $1.36Exp: 2024-01-22→ Common Stock (250 underlying)
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2023-02-21−750→ 4,892 total
    Exercise: $1.36Exp: 2024-01-22→ Common Stock (750 underlying)
  • Exercise/Conversion

    Common Stock

    2023-02-21$1.36/sh+750$1,020→ 62,310 total
  • Exercise/Conversion

    Common Stock

    2023-02-23$1.36/sh+250$340→ 62,560 total
Footnotes (1)
  • [F1]The stock option award was issued pursuant to the Sage Therapeutics, Inc. 2011 Stock Option and Incentive Plan. The option vested in full on July 23, 2016.

Documents

2 files